Sep 19 ,2023
Synopsis:
Asian markets set for a mixed start to Wednesday trade. Nikkei and Hang Seng futures little changed while ASX futures marginally lower. S&P 500 futures steady after US stocks saw mild declines in Tuesday trade. Aussie and New Zealand yields seeing more upward pressure after Treasuries weakened overnight. Dollar range-bound ahead of Fed meeting. Crude pulled back from 10-month high.
Fed widely expected to leave funds rate unchanged Wednesday. Previews not anticipating major changes to policy statement and Chair Powell expected to reiterate data dependency. Most of the attention will be on whether median dot for 2023 continues to show expectation for one more rate hike. Also thoughts 2024 median dot could be nudged higher amid sticky inflation and economic resilience. Market currently pricing in ~36% chance of another rate hike by year-end.
No change expected to China 1Y and 5Y loan prime rates after MLF rate was unchanged last week. Authorities have stepped up monetary support with PBOC cutting RRR 25 bp last Thursday, unleashing estimated CNY500B in liquidity. Central bank also injected net CNY191B in medium-term funds. Some analysts anticipate more easing in Q4, though also thoughts recent stabilization in economic activity has diminished urgency for additional support.
Surging oil prices cited as a market headwind with analysts citing risk of a move through $100 as resilient demand and Saudi/Russia production cut extension tightens supplies. Higher oil prices seen weighing on consumption while putting upward pressure on near-term headline inflation. Also concern that prolonged period of high oil prices could bleed into core inflation as companies pass on higher costs, delaying predicted rate cuts further into 2024.
Pre-open Company News:
300919.CH -- CNGR Advanced Material to establish JV with Al Mada unit for Morocco NMC precursor, lithium iron phosphate factory
1060.HK -- Alibaba Pictures Group merges with Alibaba Group's Damai for aggregate consideration of $167M (HK$1.31B)
600276.CH -- NMPA approves trial of Hengrui Pharmaceuticals' HRS-7085 tablets for intestinal inflammation
China August postal industry revenue CNY122.62B, +10.0% y/y
007070.KS -- GS Retail Co. upgraded to add from hold at CGS-CIMB
4503.JP -- NMPA accepts Astellas Pharma's NDA for XTANDI for metastatic hormone-sensitive prostate cancer
6869.HK -- Yangtze Optical Fibre & Cable Joint Stock adjusts consideration for RFS acquisition to EUR1.1M from EUR7.1M
BEC.TB -- BEC World Public Co. downgraded to sell from buy at Thanachart Securities
1801.HK -- Innovent Biologics completes 68.0M-share placement at HK$34.92/share
A50.SP -- Thomson Medical Group receives SGX-ST approval in relation to application for 3-month period to restore public float
688005.CH -- Ningbo Ronbay New Energy Technology completes 31.7M shares placement at CNY42.11/sh
603290.CH -- StarPower Semiconductor initiated overweight at JPMorgan
002311.CH -- Guangdong Haid Group terminates 33.3M-share placement to controlling shareholder as announced in April 2022
600233.CH -- YTO Express Group reports August express delivery revenue CNY4.07B, +6.2% y/y
005380.KS -- Hyundai Motor and Georgia Tech sign MoU for future mobility collaboration
On Deck:
China:
Economic:
09:30 CST: 1 Year Loan Prime Rate; consensus
Japan:
Economic:
08:50 JST: Import NSA Y/Y (Preliminary); consensus (17%)
08:50 JST: Export NSA Y/Y (Preliminary); consensus (0.5%)
08:50 JST: Trade Balance NSA (Preliminary); consensus
Earnings:
TSURUHA Holdings (3391.JP)
New Zealand:
Economic:
10:45 NZST: Current Account; consensus
Earnings:
New Zealand King Salmon Investments (NZK.NZ)
Malaysia:
Earnings:
Top Glove Corp. (7113.MK)
Market Data:
Gold (Dec 23): ($1.10) or (0.06%) to $1952.60
WTI Crude (Oct 23): +$0.36 or +0.39% to $91.56
$-¥: +0.14 or +0.10% to 147.7500
$-KRW: +3.56 or +0.27% to 1327.6400
A$-$: +0.00 or +0.36% to 0.6460
$-INR: +0.61 or +0.74% to 83.8453
$-CNY: +0.00 or +0.05% to 7.2956
If you would like to receive the Asian Market Preview daily, please search for Asia Pre-Market Updates in Alert Manager.
This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".
DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE